15家券商给予Privia Health Group“适度买入”评级，董事和机构投资者购买股票，第三季度每股收益为0.03美元，低于市场预期的0.05美元。 15 brokerages give Privia Health Group a "Moderate Buy" rating, directors and institutional investors purchase shares, Q3 EPS of $0.03 misses $0.05 consensus estimate.

普利维亚健康集团 (NASDAQ:PRVA) 已获得15家经纪公司的"中等购买"评级,平均1年价格目标为24.79美元. Privia Health Group (NASDAQ: PRVA) has received a consensus "Moderate Buy" rating from 15 brokerages, with an average 1-year price target of $24.79. 最近的内部交易包括公司董事Adam Boehler和Thomas A. McCarthy购买股份,加拿大养恤金计划投资委员会和Nisa投资顾问有限公司等机构投资者在公司投资。 Recent insider transactions include directors Adam Boehler and Thomas A. McCarthy purchasing shares, and institutional investors such as Canada Pension Plan Investment Board and Nisa Investment Advisors LLC have made investments in the company. Privia Health Group公布第三季度每股收益为0.03美元，低于市场预期的0.05美元，较差0.02美元，营收为4.223亿美元。 Privia Health Group reported Q3 earnings of $0.03 EPS, missing the consensus estimate of $0.05 by $0.02, and revenue of $422.30 million.